Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris.

Authors :: Boch K
Langan EA
Van Beek N
Kridin K
Schmidt E
Zillikens D
Ludwig RJ
Hammers CM
Bieber K
Source :: Acta dermato-venereologica [Acta Derm Venereol] 2022 Dec 13; Vol. 102, pp. adv00835. Date of Electronic Publication: 2022 Dec 13.
Publication Year :: 2022

Subjects :: Humans
Autoantibodies
Immunoglobulin G
Rituximab adverse effects
Desmoglein 1
Pemphigus diagnosis
Pemphigus drug therapy

Full Text Access

Tools